Drug control of hyperglycemia and inhibition of insulin secretion due to centrally administered 2-deoxy-D-glucose.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001337:Autonomic Agents / Q000494:pharmacology*; D004357:Drug Synergism; D005260:Female; D005947:Glucose / Q000008:administration & dosage*; D006892:Hydroxydopamines / Q000494:pharmacology; D006943:Hyperglycemia / Q000139:chemically induced*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008781:Methyltyrosines / Q000494:pharmacology; D010276:Parasympatholytics; D010646:Phentolamine / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats
D001337:Autonomic Agents; D006892:Hydroxydopamines; D007328:Insulin; D008781:Methyltyrosines; D010276:Parasympatholytics; D001285:Atropine; D011433:Propranolol; D000661:Amphetamine; D005947:Glucose; D010646:Phentolamine